Haleon has named Carl Haney as its new Chief R&D Officer, bringing decades of experience from Estée Lauder and Procter & Gamble to lead innovation for brands like Advil, Centrum, and Theraflu. Haney is known for championing consumer-led innovation while driving efficiency across complex global networks. His focus on end-to-end integration, connecting R&D with value chain operations, signals a continued shift toward more collaborative, outcome-driven product development in the consumer health space. It’s a timely reminder that today’s most effective innovation strategies are built not just in the lab, but across the entire enterprise.
